2 results match your criteria: "Chi-Mei Medical Center and Taipei Medical University[Affiliation]"
Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis.
J Clin Pathol
September 2019
Department of Diagnostic Pathology, Kobe City Medical Center General Hospital, Kobe, Japan
Aims: To elucidate the clinicopathological and molecular features of intravascular NK/T-cell lymphoma (IVNKTCL).
Methods: Two cases of IVNKTCL were retrieved from a single-centre cohort composed of 25 intravascular lymphomas. Whole-exome and RNA sequencing and immunohistochemistry were performed.
Suppression of plasma matrix metalloproteinase-9 following montelukast treatment in childhood asthma.
Pediatr Int
December 2007
Department of Pathology, Chi-Mei Medical Center and Taipei Medical University, Taipei, Taiwan.
Background: Montelukast and ketotifen are commonly prescribed anti-inflammatory medications used in the treatment of childhood asthma.
Methods: To investigate the modulation effect of montelukast and ketotifen, the levels of exhaled nitric oxide (eNO) and plasma matrix metalloproteinase-9 (MMP-9) were analyzed in a group of 30 children with mild persistent asthma.
Results: Patients on montelukast therapy for 8 weeks had significantly decreased levels of eNO and plasma MMP-9, which were associated with improved symptoms and enhanced peak expiratory flow but not significantly associated with increased level of tissue inhibitor metalloproteinase-1 (TIMP-1).